Validation of the GALAD Model and Establishment of GAAP Model for Diagnosis of Hepatocellular Carcinoma in Chinese Patients

PURPOSE: GALAD is a statistical model for estimating the likelihood of having hepatocellular carcinoma (HCC) based on gender, age, AFP, AFP-L3, and PIVKA-II. We aimed to assess its performance and build new models in China, where hepatitis B virus (HBV) is the leading etiology of HCC. PATIENTS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Miaoxia, Wu, Ruihong, Liu, Xu, Xu, Hongqin, Chi, Xiumei, Wang, Xiaomei, Zhan, Mengru, Wang, Bao, Peng, Fei, Gao, Xiuzhu, Shi, Ying, Wen, Xiaoyu, Ji, Yali, Jin, Qinglong, Niu, Junqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591054/
https://www.ncbi.nlm.nih.gov/pubmed/33123501
http://dx.doi.org/10.2147/JHC.S271790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591054/
https://www.ncbi.nlm.nih.gov/pubmed/33123501
http://dx.doi.org/10.2147/JHC.S271790

Ejemplares similares